Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50,580,036
-
Total 13F shares
-
15,622,520
-
Share change
-
+2,927,582
-
Total reported value
-
$119,504,221
-
Price per share
-
$7.65
-
Number of holders
-
67
-
Value change
-
+$17,285,176
-
Number of buys
-
34
-
Number of sells
-
32
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2020
As of 31 Mar 2020,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,622,520 shares.
The largest 10 holders included
FMR LLC, SV Health Investors, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Vivo Capital, LLC, Ikarian Capital, LLC, BlackRock Inc., PICTET ASSET MANAGEMENT LTD, Polar Capital LLP, VANGUARD GROUP INC, and ORBIMED ADVISORS LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.